Coordinated topoisomerase function shapes the fluoroquinolone response of Chlamydia trachomatis
Abstract
DNA supercoiling is essential for the developmental cycle of Chlamydia trachomatis , yet its role in shaping antibiotic responses remains poorly understood. We investigated how the fluoroquinolone moxifloxacin (Mox) influenced C. trachomatis growth across developmental stages with its distinct supercoiling levels. Early Mox exposure completely halted bacterial growth, whereas treatment during mid-cycle produced enlarged, persistent forms and abolished formation of infectious progeny. These stage-specific outcomes coincided with inhibition of DNA replication, depletion of DNA gyrase, and transcriptional repression of ompA and omcB , accompanied by preserved or elevated expression of the stress-responsive groESL1 operon. Mox also elicited compensatory downregulation of topoisomerase I (TopA), consistent with attempts to rebalance intracellular supercoiling. Together, these data demonstrate that fluoroquinolone susceptibility in C. trachomatis reflects stage-dependent supercoiling levels. Perturbation of supercoiling homeostasis drives developmental arrest and persistence phenotypes, highlighting coordinated gyrase-TopA activity as a key determinant of fluoroquinolone tolerance and a potential target for overcoming persistent infection.
Importance: C. trachomatis , a medically significant bacterial pathogen, can persist under antimicrobial pressure, complicating treatment strategy. This study links supercoiling homeostasis to fluoroquinolone tolerance, offering mechanistic…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.